Yifeng Pharmacy Chain Co (603939) Fair Value & Analysis
Healthcare · CN · Market cap 26.4B CNY
Fair value as of: Jun 24, 2026
Analysis
Yifeng Pharmacy Chain Co (603939) currently trades at ¥19.75, while our model-based Fair Value estimate is ¥29.07 — implying the stock looks roughly 47.2% undervalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. The company offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to health. It is also involved in chronic disease management, medical project investment, and medical technology development, as well as operates internet hospitals and clinics. The company also offers its products through franchise distribution and e-commerce. Yifeng Pharmacy Chain Co., Ltd. was founded in 2001 and is headquartered in Changsha, China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Yifeng Pharmacy Chain Co (603939) undervalued?
What is the fair value of 603939?
What is the quality score of 603939?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.